Sirolimus Tablet, Sugar Coated
Pricing Report NDC 59762-1002-1

Current NADAC: $0.72296 per EA · Effective Sep 23, 2026 · Est. package price $72.30 (100 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Sirolimus (NDC 59762-1002-1) is $0.72296 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 23, 2026.

As a a human prescription drug provided by Mylan Pharmaceuticals Inc., this medication is distributed in a 100 TABLET, SUGAR COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.72296
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 23, 2026
Billable Units
100 EA
Estimated Package Price
$72.30
Data Status
As of Oct 07, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
59762-1002-1
Description
100 TABLET, SUGAR COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.72296 to $13.52604 per EA. Over this 11 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.7230 - $13.5260
Market Volatility
1,770.93% Variance
Latest Trend
13.42%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $0.72296 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 19, 2026 $0.83503 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2026 $0.87498 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2026 $0.95162 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $1.00713 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $1.11846 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $1.32625 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $1.43492 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $1.42395 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $1.45149 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $1.38123 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $1.47786 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026